Table S2 from Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1–positive Triple-negative Breast Cancer Article Swipe
Jodi M. Carter
,
Mei‐Yin C. Polley
,
Roberto A. Leon‐Ferre
,
Jason P. Sinnwell
,
Kevin J. Thompson
,
Xue Wang
,
Yaohua Ma
,
David Zahrieh
,
Jennifer M. Kachergus
,
Malvika Solanki
,
Judy C. Boughey
,
Minetta C. Liu
,
James N. Ingle
,
Krishna R. Kalari
,
Fergus J. Couch
,
E. Aubrey Thompson
,
Matthew P. Goetz
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.24263003.v1
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.24263003.v1
Inter-Assay Agreement between PD-L1 SP142 and 22C3 Assay Scores in TNBC TMA
Related Topics
Concepts
Stage (stratigraphy)
Table (database)
Breast cancer
Immune system
Triple-negative breast cancer
Oncology
Cancer
Medicine
Internal medicine
Biology
Immunology
Computer science
Data mining
Paleontology
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1158/1078-0432.24263003.v1
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4387396998
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4387396998Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/1078-0432.24263003.v1Digital Object Identifier
- Title
-
Table S2 from Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1–positive Triple-negative Breast CancerWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-10-06Full publication date if available
- Authors
-
Jodi M. Carter, Mei‐Yin C. Polley, Roberto A. Leon‐Ferre, Jason P. Sinnwell, Kevin J. Thompson, Xue Wang, Yaohua Ma, David Zahrieh, Jennifer M. Kachergus, Malvika Solanki, Judy C. Boughey, Minetta C. Liu, James N. Ingle, Krishna R. Kalari, Fergus J. Couch, E. Aubrey Thompson, Matthew P. GoetzList of authors in order
- Landing page
-
https://doi.org/10.1158/1078-0432.24263003.v1Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1158/1078-0432.24263003.v1Direct OA link when available
- Concepts
-
Stage (stratigraphy), Table (database), Breast cancer, Immune system, Triple-negative breast cancer, Oncology, Cancer, Medicine, Internal medicine, Biology, Immunology, Computer science, Data mining, PaleontologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4387396998 |
|---|---|
| doi | https://doi.org/10.1158/1078-0432.24263003.v1 |
| ids.doi | https://doi.org/10.1158/1078-0432.24263003.v1 |
| ids.openalex | https://openalex.org/W4387396998 |
| fwci | 0.0 |
| type | preprint |
| title | Table S2 from Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1–positive Triple-negative Breast Cancer |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10158 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998000264167786 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | Cancer Immunotherapy and Biomarkers |
| topics[1].id | https://openalex.org/T10619 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9976999759674072 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2746 |
| topics[1].subfield.display_name | Surgery |
| topics[1].display_name | Esophageal Cancer Research and Treatment |
| topics[2].id | https://openalex.org/T10580 |
| topics[2].field.id | https://openalex.org/fields/24 |
| topics[2].field.display_name | Immunology and Microbiology |
| topics[2].score | 0.9854999780654907 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2403 |
| topics[2].subfield.display_name | Immunology |
| topics[2].display_name | Immunotherapy and Immune Responses |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C146357865 |
| concepts[0].level | 2 |
| concepts[0].score | 0.7030839920043945 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q1123245 |
| concepts[0].display_name | Stage (stratigraphy) |
| concepts[1].id | https://openalex.org/C45235069 |
| concepts[1].level | 2 |
| concepts[1].score | 0.5658140182495117 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q278425 |
| concepts[1].display_name | Table (database) |
| concepts[2].id | https://openalex.org/C530470458 |
| concepts[2].level | 3 |
| concepts[2].score | 0.5572192668914795 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q128581 |
| concepts[2].display_name | Breast cancer |
| concepts[3].id | https://openalex.org/C8891405 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5270932912826538 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[3].display_name | Immune system |
| concepts[4].id | https://openalex.org/C2780110267 |
| concepts[4].level | 4 |
| concepts[4].score | 0.45791521668434143 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q7843332 |
| concepts[4].display_name | Triple-negative breast cancer |
| concepts[5].id | https://openalex.org/C143998085 |
| concepts[5].level | 1 |
| concepts[5].score | 0.41842398047447205 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[5].display_name | Oncology |
| concepts[6].id | https://openalex.org/C121608353 |
| concepts[6].level | 2 |
| concepts[6].score | 0.3586770296096802 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[6].display_name | Cancer |
| concepts[7].id | https://openalex.org/C71924100 |
| concepts[7].level | 0 |
| concepts[7].score | 0.3265102803707123 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[7].display_name | Medicine |
| concepts[8].id | https://openalex.org/C126322002 |
| concepts[8].level | 1 |
| concepts[8].score | 0.2793440818786621 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[8].display_name | Internal medicine |
| concepts[9].id | https://openalex.org/C86803240 |
| concepts[9].level | 0 |
| concepts[9].score | 0.21415585279464722 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[9].display_name | Biology |
| concepts[10].id | https://openalex.org/C203014093 |
| concepts[10].level | 1 |
| concepts[10].score | 0.17154788970947266 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[10].display_name | Immunology |
| concepts[11].id | https://openalex.org/C41008148 |
| concepts[11].level | 0 |
| concepts[11].score | 0.12437763810157776 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q21198 |
| concepts[11].display_name | Computer science |
| concepts[12].id | https://openalex.org/C124101348 |
| concepts[12].level | 1 |
| concepts[12].score | 0.10425719618797302 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q172491 |
| concepts[12].display_name | Data mining |
| concepts[13].id | https://openalex.org/C151730666 |
| concepts[13].level | 1 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q7205 |
| concepts[13].display_name | Paleontology |
| keywords[0].id | https://openalex.org/keywords/stage |
| keywords[0].score | 0.7030839920043945 |
| keywords[0].display_name | Stage (stratigraphy) |
| keywords[1].id | https://openalex.org/keywords/table |
| keywords[1].score | 0.5658140182495117 |
| keywords[1].display_name | Table (database) |
| keywords[2].id | https://openalex.org/keywords/breast-cancer |
| keywords[2].score | 0.5572192668914795 |
| keywords[2].display_name | Breast cancer |
| keywords[3].id | https://openalex.org/keywords/immune-system |
| keywords[3].score | 0.5270932912826538 |
| keywords[3].display_name | Immune system |
| keywords[4].id | https://openalex.org/keywords/triple-negative-breast-cancer |
| keywords[4].score | 0.45791521668434143 |
| keywords[4].display_name | Triple-negative breast cancer |
| keywords[5].id | https://openalex.org/keywords/oncology |
| keywords[5].score | 0.41842398047447205 |
| keywords[5].display_name | Oncology |
| keywords[6].id | https://openalex.org/keywords/cancer |
| keywords[6].score | 0.3586770296096802 |
| keywords[6].display_name | Cancer |
| keywords[7].id | https://openalex.org/keywords/medicine |
| keywords[7].score | 0.3265102803707123 |
| keywords[7].display_name | Medicine |
| keywords[8].id | https://openalex.org/keywords/internal-medicine |
| keywords[8].score | 0.2793440818786621 |
| keywords[8].display_name | Internal medicine |
| keywords[9].id | https://openalex.org/keywords/biology |
| keywords[9].score | 0.21415585279464722 |
| keywords[9].display_name | Biology |
| keywords[10].id | https://openalex.org/keywords/immunology |
| keywords[10].score | 0.17154788970947266 |
| keywords[10].display_name | Immunology |
| keywords[11].id | https://openalex.org/keywords/computer-science |
| keywords[11].score | 0.12437763810157776 |
| keywords[11].display_name | Computer science |
| keywords[12].id | https://openalex.org/keywords/data-mining |
| keywords[12].score | 0.10425719618797302 |
| keywords[12].display_name | Data mining |
| language | en |
| locations[0].id | doi:10.1158/1078-0432.24263003.v1 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/1078-0432.24263003.v1 |
| locations[1].id | pmh:oai:figshare.com:article/24263003 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S4306400572 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | OPAL (Open@LaTrobe) (La Trobe University) |
| locations[1].source.host_organization | https://openalex.org/I196829312 |
| locations[1].source.host_organization_name | La Trobe University |
| locations[1].source.host_organization_lineage | https://openalex.org/I196829312 |
| locations[1].license | cc-by |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | https://openalex.org/licenses/cc-by |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | |
| locations[1].landing_page_url | https://figshare.com/articles/journal_contribution/Table_S2_from_Characteristics_and_Spatially_Defined_Immune_micro_landscapes_of_Early-stage_PD-L1_positive_Triple-negative_Breast_Cancer/24263003 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5006782806 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-5973-0732 |
| authorships[0].author.display_name | Jodi M. Carter |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Jodi M. Carter |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5060738532 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-0106-0323 |
| authorships[1].author.display_name | Mei‐Yin C. Polley |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Mei-Yin C. Polley |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5069569795 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-0594-4441 |
| authorships[2].author.display_name | Roberto A. Leon‐Ferre |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Roberto A. Leon-Ferre |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5058853230 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-1964-5522 |
| authorships[3].author.display_name | Jason P. Sinnwell |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Jason Sinnwell |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5070464408 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-9348-4686 |
| authorships[4].author.display_name | Kevin J. Thompson |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Kevin J. Thompson |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5120218320 |
| authorships[5].author.orcid | https://orcid.org/0009-0002-1823-4086 |
| authorships[5].author.display_name | Xue Wang |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Xue Wang |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5102849202 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-4402-5464 |
| authorships[6].author.display_name | Yaohua Ma |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Yaohua Ma |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5047094317 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-0529-5146 |
| authorships[7].author.display_name | David Zahrieh |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | David Zahrieh |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5072734589 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Jennifer M. Kachergus |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Jennifer M. Kachergus |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5113962952 |
| authorships[9].author.orcid | https://orcid.org/0000-0001-6211-1599 |
| authorships[9].author.display_name | Malvika Solanki |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Malvika Solanki |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5033544737 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-3820-3228 |
| authorships[10].author.display_name | Judy C. Boughey |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Judy C. Boughey |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5027858713 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-8206-5232 |
| authorships[11].author.display_name | Minetta C. Liu |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Minetta C. Liu |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5083904553 |
| authorships[12].author.orcid | https://orcid.org/0000-0003-1257-7731 |
| authorships[12].author.display_name | James N. Ingle |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | James N. Ingle |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5085014608 |
| authorships[13].author.orcid | https://orcid.org/0000-0001-8944-8378 |
| authorships[13].author.display_name | Krishna R. Kalari |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Krishna R. Kalari |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A5016908886 |
| authorships[14].author.orcid | https://orcid.org/0000-0001-9417-9985 |
| authorships[14].author.display_name | Fergus J. Couch |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Fergus J. Couch |
| authorships[14].is_corresponding | False |
| authorships[15].author.id | https://openalex.org/A5026692399 |
| authorships[15].author.orcid | https://orcid.org/0000-0002-9001-4240 |
| authorships[15].author.display_name | E. Aubrey Thompson |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | E. Aubrey Thompson |
| authorships[15].is_corresponding | False |
| authorships[16].author.id | https://openalex.org/A5008665323 |
| authorships[16].author.orcid | https://orcid.org/0000-0002-4383-270X |
| authorships[16].author.display_name | Matthew P. Goetz |
| authorships[16].author_position | last |
| authorships[16].raw_author_name | Matthew P. Goetz |
| authorships[16].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1158/1078-0432.24263003.v1 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Table S2 from Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1–positive Triple-negative Breast Cancer |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10158 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998000264167786 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | Cancer Immunotherapy and Biomarkers |
| related_works | https://openalex.org/W3030228103, https://openalex.org/W2903919886, https://openalex.org/W2064898491, https://openalex.org/W4388541371, https://openalex.org/W2312355201, https://openalex.org/W2117246658, https://openalex.org/W1986496754, https://openalex.org/W2738153741, https://openalex.org/W2387231244, https://openalex.org/W3159161416 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1158/1078-0432.24263003.v1 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/1078-0432.24263003.v1 |
| primary_location.id | doi:10.1158/1078-0432.24263003.v1 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/1078-0432.24263003.v1 |
| publication_date | 2023-10-06 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.in | 9 |
| abstract_inverted_index.and | 5 |
| abstract_inverted_index.22C3 | 6 |
| abstract_inverted_index.TNBC | 10 |
| abstract_inverted_index.Assay | 7 |
| abstract_inverted_index.PD-L1 | 3 |
| abstract_inverted_index.SP142 | 4 |
| abstract_inverted_index.Scores | 8 |
| abstract_inverted_index.between | 2 |
| abstract_inverted_index.Agreement | 1 |
| abstract_inverted_index.TMA</p> | 11 |
| abstract_inverted_index.<p>Inter-Assay | 0 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 17 |
| citation_normalized_percentile.value | 0.47363384 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |